关键信息
-
基因名
B4GALT4
-
简介
B4GALT4 Protein, Human (HEK293, His) encodes a type II membrane protein with significant sequence similarity to other β1,4-galactosyltransferases. B4GALT4 mainly plays a role in glycolipid biosynthesis and has been recognized involving in cancer metastatic processes[1][2].
- 应用
-
别名
rHuB4GALT4, His; Beta-1,4-Galactosyltransferase 4; Beta-1,4-GalTase 4; B4GALT4
-
种属
Human
-
表达系统
HEK293
-
标签
C-6*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O60513
-
表达区间
Q39-A344
-
氨基酸序列
QEIPKAKEFMANFHKTLILGKGKTLTNEASTKKVELDNCPSVSPYLRGQSKLIFKPDLTLEEVQAENPKVSRGRYRPQECKALQRVAILVPHRNREKHLMYLLEHLHPFLQRQQLDYGIYVIHQAEGKKFNRAKLLNVGYLEALKEENWDCFIFHDVDLVPENDFNLYKCEEHPKHLVVGRNSTGYRLRYSGYFGGVTALSREQFFKVNGFSNNYWGWGGEDDDLRLRVELQRMKISRPLPEVGKYTMVFHTRDKGNEVNAERMKLLHQVSRVWRTDGLSSCSYKLVSVEHNPLYINITVDFWFGAHHHHHH
-
蛋白长度
Lumenal Domain
-
分子量
34-43 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
B4GALT4, or Beta-1,4-galactosyltransferase 4, is an important enzyme in the glycosylation process, specifically involved in synthesizing glycoproteins and glycolipids. This enzyme catalyzes the transfer of galactose to various acceptor sugars, playing a crucial role in modulating cellular interactions and signaling pathways. Mutations or malfunctions in the B4GALT4 gene have been linked to several diseases, including developmental disorders and certain neurological conditions. An increasing interest in understanding the structure and function of B4GALT4 arises from its potential impact on therapeutic applications, particularly in drug development and regenerative medicine. Additionally, the study of B4GALT4 and its recombinant protein form enables the exploration of its enzymatic activity and substrate specificity, thereby providing insights into its biological relevance. Research efforts focus on optimizing the expression and purification of the B4GALT4 recombinant protein, allowing for detailed biochemical characterization and functional assays. Understanding the mechanistic roles of B4GALT4 at a molecular level may lead to novel strategies for disease intervention and highlight its significance in the broader context of glycosylation-related disorders.
